BioPharma companies and clinical trial sites often need to complete security and compliance due diligence before working with a partner. With experience supporting pharmaceutical companies, 444+ clinical trial sites, and over 3,000 physicians, myTomorrows understands what trusted collaboration requires. The myTomorrows Trust Center provides transparent, centralized access to our certifications, compliance, security practices, and assurance documentation, including ISO 27001 and SOC 2 Type II, helping partners evaluate us quickly and confidently
At myTomorrows, trust is fundamental to everything we do.
As a company working at the intersection of healthcare, clinical research, and patient access, we process sensitive information that must be protected to the highest standards. Our partners rely on us not only to deliver operational excellence, but also to handle clinical and patient data securely, responsibly, and compliantly.
That is why information security and compliance are top priorities at myTomorrows. We are committed to establishing, implementing, maintaining, and continuously improving our information security management systems to mitigate risk and protect data. This is an ongoing commitment, supported by continuous monitoring, audits, internal governance, and improvement processes.
To demonstrate this, myTomorrows has obtained leading industry certifications, including ISO 27001 and SOC 2 Type II, aligned with the latest standards.
“We’re proud of the security and compliance standards we’ve achieved at myTomorrows. The Trust Center is an important step in making that commitment transparent, giving our valued partners clear, trusted evidence of how we protect sensitive data.”
Filippo Mandrini, Senior Security Officer at myTomorrows
Across BioPharma and clinical research, industry expectations around data protection continue to rise, with SOC 2 Type II and ISO 27001 increasingly viewed as essential baselines for vendor qualification. The Trust Center demonstrates that myTomorrows not only meets these standards but also exceeds them through continuous monitoring and proactive risk management.
A Trust Center is a centralized, publicly accessible location where an organization documents and communicates how it protects data, manages risk, and maintains compliance with security, privacy, and regulatory requirements.
In practice, a Trust Center helps answer questions such as:
Trust Centers are increasingly becoming standard for healthcare, technology, and BioPharma partners as part of vendor evaluation and risk management processes.
When evaluating a new partner, BioPharma companies and clinical trial sites must often conduct detailed due diligence compliance and security reviews.
The myTomorrows Trust Center was created to provide transparency and reassurance by offering a clear view into our security posture and governance practices.
It is valuable as it helps stakeholders:
“Through our work with leading pharmaceutical companies and research institutes, we understand how important thorough due diligence is. The Trust Center is designed to streamline that process by giving partners easy access to the security and compliance information they need to evaluate myTomorrows with confidence.”
Dennis Akkaya, Chief Commercial Officer at myTomorrows
The Trust Center reduces barriers by ensuring that clinical sites, PACs, and partners can rapidly validate our compliance posture, enabling faster collaboration, faster onboarding, and ultimately faster access for patients
Due diligence processes often involve extensive security questionnaires, documentation requests, and compliance checks.
The Trust Center helps streamline this process by providing centralized access to the information most partners need upfront.
It can support:
Rather than starting from scratch with every request, partners can use the Trust Center as a consistent source of validated information.
The Trust Center provides detailed information across key areas of security, privacy, and compliance.
myTomorrows demonstrates alignment with recognized international frameworks and regulations, including:
These certifications and frameworks help provide trusted evidence for partner compliance requirements.
The Trust Center outlines how myTomorrows protects data through security controls such as access control, infrastructure and network security, endpoint protection and secure development.
myTomorrows understands what the most critical questions during a new partner evaluation are. The Trust Center is built around these points and clarifies the most common inquiries like:
These measures are designed to mitigate risks and ensure confidentiality, integrity, and availability of sensitive information.
Security is not only about prevention, but also about preparedness.
Partners need confidence that sensitive data and critical systems remain protected not only during day-to-day operations, but also in the event of unexpected disruptions, cyber incidents, or operational risks.
The myTomorrows Trust Center provides transparency into how we manage these scenarios through structured, audited processes, including:
To support formal due diligence, the Trust Center provides access to key documentation, including:
Some documents may be available directly, while others can be requested securely depending on sensitivity and access requirements.
These reports are updated regularly, including annual SOC 2 Type II audits, periodic ISO 27001 surveillance audits, and recurring independent penetration testing, ensuring that our partners always have access to current assurance evidence.
The Trust Center also provides transparency into sub-processors and third parties involved in data processing.
This supports partner expectations around vendor ecosystem oversight and responsible data handling.
The myTomorrows Trust Center is designed to make security and compliance information easy to access in one centralized space, so partners can quickly find the evidence they need without lengthy back-and-forth.
Visitors can use the navigation menu to explore key areas such as certifications, assurance reports, security controls, and sub-processors, depending on what information is required.
It supports different stakeholder needs:
If additional documentation is required as part of a formal review, partners can also request full access to the myTomorrows Trust Center. This will allow download of documents and reports.
If you have questions about information security, compliance, or the Trust Center — or if you require additional assurance documentation, our team is here to help.
Please contact: security@mytomorrows.com
The myTomorrows Trust Center reflects our commitment to security, compliance, and transparency.
It is designed to support partners, clinical trial sites, and stakeholders who need trusted evidence as part of their due diligence process — and to build confidence in how we protect sensitive clinical and patient data.
We invite you to explore the Trust Center and reach out with any questions.
Yes. myTomorrows has obtained ISO 27001 certification, demonstrating alignment with international information security standards.
The SOC 2 Type II report is available through the Trust Center, with full access provided securely after request.
The Trust Center centralizes key certifications, policies, and assurance evidence to make vendor evaluations faster and more transparent.
About the author
Senior Security Officer at myTomorrows
Filippo Mandrini is Senior Information Security Officer at myTomorrows, where he leads information security governance, risk management, and compliance within a tech-oriented pharma scale-up. Based in Amsterdam, he supports enterprise and product security initiatives, including ISO 27001 and SOC 2 certification, secure-by-design practices, and incident response.
Filippo holds an MSc in Computer Science and Engineering with a Cybersecurity track from Politecnico di Milano and he holds several security-related certifications. Prior to joining myTomorrows, he worked as a Cyber Security Senior Consultant at EY, advising banks and insurers on regulatory compliance, cyber strategy, and security assessments.
Filippo Mandrini 19 Feb 2026